TETRABENAZINE

Tetrabenazine depletes monoamines by inhibiting VMAT2, used for Huntingtons chorea and tardive dyskinesia. Side effects include depression, drowsiness, parkinsonism, insomnia, and hypotension. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 2fca1fc0f1d9 Category: Tag:

Product Description


Mechanism of Action

TETRABENAZINE demonstrates a broad and highly integrated biochemical activity architecture involving multiaxis signalling interference, mitochondrial-network recalibration, catalyticdomain modulation, cytoskeletal restructuring, redoxequilibrium shaping, ionflux redistribution and transcriptionfactor pathway realignment. Its molecular geometry allows docking to catalytic residues, allosteric regulators, hydrophobic transmembrane helices, nucleotidebinding pockets, structural scaffolds and polymeric cytoskeletal networks. This enables TETRABENAZINE to influence metabolic, structural, genomic, electrophysiological and stressadaptive systems simultaneously.

TETRABENAZINE may modulate phosphorylation gradients, modify ERK/JNK/MAPK propagation speeds, influence PI3KAKT survival bias, shift Gprotein signalling states, control Ca²⁺ microdomain behaviour, alter IP/DAG cascades, and recalibrate cAMPPKA pathway amplitude. Mitochondrial impacts include ETCcomplex redistribution, ATP/ADP cycle reshaping, ROSthreshold displacement, membranepotential polarity changes and organellestress crosssignalling.

HighPrecision

  • Ultrascale kinome disruption & catalyticcascade modelling
  • Molecular docking & conformationalflow prediction
  • UPR/ERstress and mitophagy/autophagy integration research
  • Fullspectrum multiomics reconstruction (RNAseq, metabolomics, phosphoproteomics)
  • Advanced cytoskeletal forcedistribution & polymerturnover analysis
  • Cellfate simulation across apoptosis, ferroptosis, necroptosis & parthanatos
  • AIenhanced SAR/QSAR simulation for molecular optimisation

Toxicodynamics & Hazard Spectrum

  • Rapid ROS escalation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Severe Ca²⁺/Na⁺/K⁺ ionflux destabilisation
  • Cytoskeletal polymer breakdown & structuralintegrity failure
  • Membrane rupture & lipidbilayer thinning
  • Overactivation of inflammatory cascades (NF-κB, STAT, IRF)
  • Activation of multiple programmed-cell-death pathways
  • Epigenetic drift including methylation instability

For expert not intended for biological exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C19H27NO3

Molecular Weight

317.4 g/mol

CAS Number

58-46-8

Storage Condition

Store at 25 °C (77 °F); excursions permitted to 15 deg to 30 °C (59 deg to 86 °F).

Solubility

Sparingly soluble

Purity

Purity information is available upon request (COA).

Synonym

TETRABENAZINE; 58-46-8; Nitoman; Xenazine; Tetrabenazina

IUPAC/Chemical Name

9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one

InChl Key

MKJIEFSOBYUXJB-UHFFFAOYSA-N

InChl Code

InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/6018;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download